10 employees
Greenstone Biosciences is a drug discovery platform that accelerates the development of effective therapies for patients.
2022
$2.8M
from 1 investors over 1 rounds
Greenstone Biosciences raised $2.8M on September 12, 2023
Investors: National Institutes of Health